BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3247845)

  • 1. [Histomorphological changes in nasal polyps in patients with glucose metabolism disorders].
    Bellioni P; Lombardi R; Ruscito P; Artuso A; D'Alatri L
    Acta Otorhinolaryngol Ital; 1988; 8(6):591-603. PubMed ID: 3247845
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of platelet-activating factor in nasal polyps and eosinophils.
    Furukawa M; Ogura M; Tsutsumi T; Tsuji H; Yamashita T
    Acta Otolaryngol; 2002 Dec; 122(8):872-6. PubMed ID: 12542208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of mast cells in the etiopathogenesis of nasal polyps].
    Bellioni P; Ruscito P; Bevilacqua P; Ciancaglini A; Di Luzio Paparatti U; Maggiano N; Larocca LM
    Acta Otorhinolaryngol Ital; 1988; 8(4):371-83. PubMed ID: 3232520
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of stem cell factor expression in nasal polyp epithelial cells with aspirin sensitivity and asthma.
    Kowalski ML; Lewandowska-Polak A; Woźniak J; Ptasińska A; Jankowski A; Wagrowska-Danilewicz M; Danilewicz M; Pawliczak R
    Allergy; 2005 May; 60(5):631-7. PubMed ID: 15813808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct features of chronic rhinosinusitis with and without nasal polyps.
    Polzehl D; Moeller P; Riechelmann H; Perner S
    Allergy; 2006 Nov; 61(11):1275-9. PubMed ID: 17002702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrastructure of endonasal polyposis].
    Jahnke V
    Z Laryngol Rhinol Otol; 1972 May; 51(5):323-30. PubMed ID: 5042765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mast cells in eosinophilic and neutrophilic nasal polyps. Cytological and histological examinations].
    Miszke A; Sanokowska E; Lis G
    Otolaryngol Pol; 1998; 52(3):321-6. PubMed ID: 9760776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.
    Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP
    J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps.
    Seto H; Suzaki H; Shioda S
    Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in connective tissue metabolism in fibroblasts from nasal polyps].
    Umbach B; Hennebach U
    HNO; 1994 Jun; 42(6):344-9. PubMed ID: 8071094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors influencing the eosinophil infiltration of nasal polyps.
    Jankowski R; Bouchoua F; Coffinet L; Vignaud JM
    Rhinology; 2002 Dec; 40(4):173-8. PubMed ID: 12526243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of erythromycin on apoptosis of eosinophils in nasal polyps in vitro].
    Tang J; Li Y; Xu G; Xu R; Zhang G; Liu X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):127-9. PubMed ID: 12768725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps.
    Iino Y; Miyazawa T; Kakizaki K; Saigusa H; Katano H; Shiga J; Kanegasaki S
    Acta Otolaryngol; 2006 Jan; 126(1):43-50. PubMed ID: 16308254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of vascular endothelial growth factor and transforming growth factor-beta 1 in nasal polyps].
    Guo J; Wang X; Tao G; Zhang H; Zhu X; Zhang W; Fan E; Han D
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):83-6. PubMed ID: 12761968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mast cells in the nasal mucosa of patients with nasal polyps. A histological study with lectins].
    Melgarejo Moreno P; Hellín Meseguer D; Sarroca Capell E
    An Otorrinolaringol Ibero Am; 1998; 25(1):23-8. PubMed ID: 9542244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Melatonin expression in nasal polyps in patients with asthmatic triad].
    Evsiukova EV; Okuneva EIu; Zubzhitskaia LB; Kvetnoĭ IM
    Arkh Patol; 2008; 70(3):33-5. PubMed ID: 18727430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
    Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
    Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estradiol receptors expression in nasal polyps and its significance].
    Dong Z; Zhao X; Yang Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(3):162-4. PubMed ID: 9639716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps.
    Hyo S; Kawata R; Kadoyama K; Eguchi N; Kubota T; Takenaka H; Urade Y
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):693-700. PubMed ID: 17638783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
    Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
    Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.